Microbiota restoration for recurrent Clostridioides difficile : Getting one step closer every day!
出版年份 2021 全文链接
标题
Microbiota restoration for recurrent
Clostridioides difficile
: Getting one step closer every day!
作者
关键词
-
出版物
JOURNAL OF INTERNAL MEDICINE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-04-16
DOI
10.1111/joim.13290
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
- (2021) Srishti Saha et al. GASTROENTEROLOGY
- Therapies to modulate gut microbiota: Past, present and future
- (2020) Akshita Gupta et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection
- (2020) Sahil Khanna et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- SER-109, an Investigational Microbiome Drug to Reduce Recurrence after Clostridioides difficile infection: Lessons Learned from a Phase 2 Trial
- (2020) Barbara H McGovern et al. CLINICAL INFECTIOUS DISEASES
- Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection
- (2020) Elida Voth et al. Expert Review of Anti-Infective Therapy
- Update on Treatment of Clostridioides difficile Infection
- (2020) Janice M. Cho et al. MAYO CLINIC PROCEEDINGS
- Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes
- (2020) Alice Y. Guh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
- (2020) Raseen Tariq et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- The Integrative Human microbiome project: a mile stone in the understanding of the gut microbiome
- (2020) Elida Voth et al. Expert Review of Gastroenterology & Hepatology
- Durability Of Response To Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence In Patients With Clostridioides difficile Infection
- (2020) Srishti Saha et al. CLINICAL INFECTIOUS DISEASES
- RBX7455, a Room Temperature-Stable, Orally-Administered Investigational Live Biotherapeutic, is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections
- (2020) Sahil Khanna et al. CLINICAL INFECTIOUS DISEASES
- Fecal Microbiota Transplantation: Tales of Caution
- (2020) Sahil Khanna et al. CLINICAL INFECTIOUS DISEASES
- Shiga toxin-producing E. coli transmission via fecal microbiota transplant
- (2020) Caroline Zellmer et al. CLINICAL INFECTIOUS DISEASES
- Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry
- (2020) Colleen R. Kelly et al. GASTROENTEROLOGY
- Gut microbiota in human metabolic health and disease
- (2020) Yong Fan et al. NATURE REVIEWS MICROBIOLOGY
- 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients
- (2019) Massimo Sartelli et al. World Journal of Emergency Surgery
- Mo1955 – Ve303, a Live Biotherapeutic Product for Prevention of Recurrent Clostridioides Difficile (C. Difficile) Infection. Preliminary Results of a Phase 1, Open-Label Healthy Volunteers Study of Oral Ve303 After Vancomycin
- (2019) Dmitri Bobilev et al. GASTROENTEROLOGY
- A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection
- (2019) Theodore Rokkas et al. United European Gastroenterology Journal
- Donor Screening for Fecal Microbiota Transplantation
- (2019) Zain Kassam et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
- (2019) Zachariah DeFilipp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease
- (2019) Raseen Tariq et al. INFLAMMATORY BOWEL DISEASES
- Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection
- (2018) Erik R Dubberke et al. CLINICAL INFECTIOUS DISEASES
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
- (2018) Dale N Gerding et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
- (2018) L Clifford McDonald et al. CLINICAL INFECTIOUS DISEASES
- Evaluation of 4 molecular assays as part of a 2-step algorithm for the detection of Clostridium difficile in stool specimens
- (2018) Adam J. Caulfield et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- What do we know about the diagnostics, treatment and epidemiology of Clostridioides ( Clostridium ) difficile infection in Europe?
- (2018) Elisabeth Nagy JOURNAL OF INFECTION AND CHEMOTHERAPY
- Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis
- (2018) Raseen Tariq et al. CLINICAL INFECTIOUS DISEASES
- Diagnosis and Treatment of Clostridium difficile Infection
- (2018) Arjun Gupta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial
- (2018) Zhi-Dong Jiang et al. PLoS One
- Fecal Microbiota Transplantation
- (2017) Arjun Gupta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection
- (2017) Dina Kao et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
- (2017) Richard J Vickers et al. LANCET INFECTIOUS DISEASES
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- The incidence and outcomes from Clostridium difficile infection in hospitalized adults with inflammatory bowel disease
- (2017) George Saffouri et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection
- (2017) Raseen Tariq et al. JAMA Internal Medicine
- Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease
- (2017) Sahil Khanna et al. Microbiome
- RBX2660 is Safe, Superior to Antibiotic-Treated Controls for Preventing Recurrent Clostridium difficile, and May Rehabilitate Patient Microbiomes: Open Label Trial Results
- (2017) Robert Orenstein et al. Open Forum Infectious Diseases
- High risk of post-infectious irritable bowel syndrome in patients withClostridium difficileinfection
- (2016) A. Wadhwa et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- RecurrentClostridium difficileinfection associates with distinct bile acid and microbiome profiles
- (2016) J. R. Allegretti et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Predictors of Early Failure After Fecal Microbiota Transplantation for the Therapy of Clostridium Difficile Infection: A Multicenter Study
- (2016) Monika Fischer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection
- (2016) Colleen R. Kelly et al. ANNALS OF INTERNAL MEDICINE
- Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
- (2016) Alexander Khoruts et al. Clinical Gastroenterology and Hepatology
- Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for RecurrentClostridium difficileInfection: An Open-Label, Randomized Controlled Trial
- (2016) Susy S. Hota et al. CLINICAL INFECTIOUS DISEASES
- Repeat Clostridium difficile Testing
- (2016) Arjun Gupta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection
- (2016) Christine H. Lee et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection
- (2016) Raseen Tariq et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents RecurrentClostridium difficileInfection
- (2016) Sahil Khanna et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical implications of antibiotic impact on gastrointestinal microbiota andClostridium difficileinfection
- (2016) Sahil Khanna et al. Expert Review of Gastroenterology & Hepatology
- Systematic Review: Adverse Events of Fecal Microbiota Transplantation
- (2016) Sinan Wang et al. PLoS One
- Safety and Durability of RBX2660 (Microbiota Suspension) for RecurrentClostridium difficileInfection: Results of the PUNCH CD Study
- (2015) Robert Orenstein et al. CLINICAL INFECTIOUS DISEASES
- Fecal Microbiota Transplant for Relapsing Clostridium difficile Infection Using a Frozen Inoculum From Unrelated Donors: A Randomized, Open-Label, Controlled Pilot Study
- (2014) Ilan Youngster et al. CLINICAL INFECTIOUS DISEASES
- Oral, Capsulized, Frozen Fecal Microbiota Transplantation for RelapsingClostridium difficileInfection
- (2014) Ilan Youngster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
- (2013) S.B. Debast et al. CLINICAL MICROBIOLOGY AND INFECTION
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Standardized Frozen Preparation for Transplantation of Fecal Microbiota for Recurrent Clostridium difficile Infection
- (2012) Matthew J Hamilton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection
- (2012) Lawrence J Brandt et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI
- (2012) T. J. Louie et al. CLINICAL INFECTIOUS DISEASES
- The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study
- (2011) Sahil Khanna et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The growing incidence and severity ofClostridium difficileinfection in inpatient and outpatient settings
- (2010) Sahil Khanna et al. Expert Review of Gastroenterology & Hepatology
- Decreased Diversity of the Fecal Microbiome in RecurrentClostridium difficile–Associated Diarrhea
- (2008) Ju Young Chang et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search